Cymat Stock Today

CYM Stock  CAD 0.45  0.01  2.17%   
Market Performance
2 of 100
Odds Of Distress
Over 75
Cymat Technologies is selling for under 0.45 as of the 6th of February 2023; that is -2.17 percent decrease since the beginning of the trading day. The stock's lowest day price was 0.45. Cymat Technologies has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Equity ratings for Cymat Technologies are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 7th of January 2023 and ending today, the 6th of February 2023. Click here to learn more.
Fiscal Year End
April
Category
Industrials
ISIN
CA23257A2083
Cymat Technologies Ltd., a materials technology company, manufactures and sells stabilized aluminum foam products worldwide. It also provides architectural materials under the Alusion brand name and automotive and blast mitigation products under the SmartMetal brand name. The company has 59.09 M outstanding shares of which 15.1 K shares are currently shorted by private and institutional investors with about 0.24 days to cover all short positions. More on Cymat Technologies
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Cymat Technologies Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Cymat Technologies' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Cymat Technologies or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ChairmanMichael Liik
Macroaxis Advice
The buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Cymat Technologies' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Strong SellOvervalued
Cymat Technologies (CYM) is traded on TSX Venture Exchange in Canada and employs 12 people. The company currently falls under 'Micro-Cap' category with a current market capitalization of 26.59 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cymat Technologies's market, we take the total number of its shares issued and multiply it by Cymat Technologies's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Cymat Technologies classifies itself under Industrials sector and is part of Metal Fabrication industry. The entity has 59.09 M outstanding shares of which 15.1 K shares are currently shorted by private and institutional investors with about 0.24 days to cover all short positions. Cymat Technologies has accumulated about 181.66 K in cash with (4.32 M) of positive cash flow from operations.
Check Cymat Technologies Probability Of Bankruptcy
Ownership
Cymat Technologies holds a total of fifty-nine million eighty-five thousand six hundred outstanding shares. Cymat Technologies shows 6.277 percent if its outstanding shares held by insiders and 6.277 percent owned by other corporate entities . Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation

Check Cymat Ownership Details

Cymat Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of Cymat Technologies jumping above the current price in 90 days from now is about 14.27%. The Cymat Technologies probability density function shows the probability of Cymat Technologies stock to fall within a particular range of prices over 90 days. Assuming the 90 days horizon Cymat Technologies has a beta of 0.1809 suggesting as returns on the market go up, Cymat Technologies average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Cymat Technologies will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1688, implying that it can generate a 0.17 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 0.45HorizonTargetOdds Above 0.45
85.65%90 days
 0.45 
14.27%
Based on a normal probability distribution, the odds of Cymat Technologies to move above the current price in 90 days from now is about 14.27 (This Cymat Technologies probability density function shows the probability of Cymat Stock to fall within a particular range of prices over 90 days) .

Cymat Technologies Risk Profiles

Investors will always prefer to have the highest possible return on investment while minimizing volatility. Cymat Technologies market risk premium is the additional return an investor will receive from holding Cymat Technologies long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Cymat Technologies. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Cymat Technologies' alpha and beta are two of the key measurements used to evaluate Cymat Technologies' performance over the market, the standard measures of volatility play an important role as well.

Cymat Stock Against Markets

Picking the right benchmark for Cymat Technologies stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Cymat Technologies stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Cymat Technologies is critical whether you are bullish or bearish towards Cymat Technologies at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Cymat Technologies without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Watchlist Optimization Now

   

Watchlist Optimization

Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
All  Next Launch Module

Cymat Technologies Corporate Directors

Cymat Technologies corporate directors refer to members of a Cymat Technologies board of directors. The board of directors generally takes responsibility for the Cymat Technologies' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Cymat Technologies' board members must vote for the resolution. The Cymat Technologies board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
William Pettipas - Independent DirectorProfile
Martin Mazza - Independent DirectorProfile
Lewis MacKenzie - Independent DirectorProfile
Jon Gill - Independent DirectorProfile

Invested in Cymat Technologies?

The danger of trading Cymat Technologies is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Cymat Technologies is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Cymat Technologies. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Cymat Technologies is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Continue to Trending Equities. You can also try Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Complementary Tools for analysis

When running Cymat Technologies price analysis, check to measure Cymat Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cymat Technologies is operating at the current time. Most of Cymat Technologies' value examination focuses on studying past and present price action to predict the probability of Cymat Technologies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Cymat Technologies' price. Additionally, you may evaluate how the addition of Cymat Technologies to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Please note, there is a significant difference between Cymat Technologies' value and its price as these two are different measures arrived at by different means. Investors typically determine Cymat Technologies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cymat Technologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.